Stroke Post Processing Software Market Scope
The software is fast, automated, and results can be viewed on any computer or handheld device by the treating physician on the medical staff. Technology is the world's most advanced visualization software for the brain. The fully automated solution provides specialists with accurate quantitative maps within seconds that show unprecedented accuracy, allowing physicians to rapidly assess the severity of patients’ strokes – and determine the most appropriate treatment based on available collateral circulation. According to the Centers for Disease Control and Prevention, stroke is the fifth leading cause of death in the United States and is a major cause of serious disability for adults. Nearly 795,000 people in the United States have a stroke each year. The rate of stroke-related deaths and stroke prevalence is slowly declining in some countries. In Sweden, for instance, estimates from 2000 predicted a 50% increase in stroke incidence by 2050 from less than 30,000 to about 43,000 strokes a year. European policymakers, predict a 34% rise in the number of people having strokes by 2035.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that European Players will contribute to the maximum growth of Global Stroke Post Processing Software market throughout the predicted period.
Brainomix (United Kingdom), Viz.ai, Inc. (United States), iSchemaView, Inc. (United States), General Electric Company (United States), Koninklijke Philips NV (Netherlands), Siemens(Germany), SpinTech, Inc. (United States), Cercare Medical ApS (Norway), Mātai Medical Research Institute Inc. (New Zealand), Apollo Medical Imaging Technology (Australia), Olea Medical (France), inferVISION (China), JLK Inspection (South Korea) and Zebra Medical Vision (Israel) are some of the key players that are part of study coverage.
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Segmentation Overview
The study have segmented the market of Global Stroke Post Processing Software market by Type (Ischemic Stroke, Hemorrhagic Stroke and Others) and Region with country level break-up.
On the basis of geography, the market of Stroke Post Processing Software has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Trend
- Growing Affordability of Cardio Vascular Treatments and Increasing Disposable Incomes
- Introduction to Highly Efficient Cardiac Biomarkers and Minimally Invasive Stroke Management Tools
Market Drivers
- Growth of Research and Developments in Tackling Critical Heart Diseases
- Rising Prevalence of Cardio-Vascular Diseases across the Globe
Opportunities
- Increasing R&D Infrastructure in Healthcare across the Developing Nations
- Rising Consumer Eagerness towards Healthcare Expenditure
Restraints
- Stringent Government Regulations on Approval
Challenges
- Need to improve the devices’ clinician interface threatened continuous growth and profitability
Key Target Audience
Stroke Software Providers, Healthcare Industry, Potential Investors, Regulatory Bodies and Others